Leash

leash.bio

Leash Biosciences is transforming drug design through machine learning by building a proprietary dataset of protein-molecule interactions. They have measured 17.4 billion interactions and designed 6.7 million molecules, focusing on closing the data gap in drug discovery. Their innovative software rapidly designs new molecules, making them more likely to succeed in drug development. With plans to measure 500 protein targets against 20 million molecules, they are positioned to develop new medicines, particularly in oncology, while collaborating with biopharma partners to explore new opportunities.